CN114209622A - 一种渗透肌肤的小分子组合物及其制备工艺 - Google Patents
一种渗透肌肤的小分子组合物及其制备工艺 Download PDFInfo
- Publication number
- CN114209622A CN114209622A CN202111488212.5A CN202111488212A CN114209622A CN 114209622 A CN114209622 A CN 114209622A CN 202111488212 A CN202111488212 A CN 202111488212A CN 114209622 A CN114209622 A CN 114209622A
- Authority
- CN
- China
- Prior art keywords
- skin
- sodium hyaluronate
- stirring
- phase
- hydrolyzed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 17
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 150000003384 small molecules Chemical class 0.000 title claims description 13
- 239000000463 material Substances 0.000 claims abstract description 39
- 229920002385 Sodium hyaluronate Polymers 0.000 claims abstract description 28
- 229940010747 sodium hyaluronate Drugs 0.000 claims abstract description 28
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 28
- 229920002674 hyaluronan Polymers 0.000 claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 12
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims abstract description 11
- 229960003160 hyaluronic acid Drugs 0.000 claims abstract description 11
- 229920006037 cross link polymer Polymers 0.000 claims abstract description 8
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims abstract description 7
- 229940015975 1,2-hexanediol Drugs 0.000 claims abstract description 7
- SCVVSSZVLZQUDZ-UHFFFAOYSA-N 3-methyl-2,6-dihydro-1H-pyrimidine-2-carboxylic acid Chemical compound CN1C(NCC=C1)C(=O)O SCVVSSZVLZQUDZ-UHFFFAOYSA-N 0.000 claims abstract description 7
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229920002498 Beta-glucan Polymers 0.000 claims abstract description 7
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 claims abstract description 7
- 108010087806 Carnosine Proteins 0.000 claims abstract description 7
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 claims abstract description 7
- 241000736199 Paeonia Species 0.000 claims abstract description 7
- 235000006484 Paeonia officinalis Nutrition 0.000 claims abstract description 7
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims abstract description 7
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims abstract description 7
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 claims abstract description 7
- 229940044199 carnosine Drugs 0.000 claims abstract description 7
- 150000002148 esters Chemical class 0.000 claims abstract description 7
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims abstract description 7
- 108010038807 Oligopeptides Proteins 0.000 claims abstract description 4
- 102000015636 Oligopeptides Human genes 0.000 claims abstract description 4
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims abstract description 4
- 238000003756 stirring Methods 0.000 claims description 27
- 238000001816 cooling Methods 0.000 claims description 9
- 230000000249 desinfective effect Effects 0.000 claims description 3
- 238000001514 detection method Methods 0.000 claims description 3
- 238000007599 discharging Methods 0.000 claims description 3
- 230000001804 emulsifying effect Effects 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 229940119170 jojoba wax Drugs 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 238000012856 packing Methods 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- 238000005070 sampling Methods 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims description 2
- 230000000149 penetrating effect Effects 0.000 claims 1
- 230000037303 wrinkles Effects 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 6
- 206010051246 Photodermatosis Diseases 0.000 abstract description 4
- 230000032683 aging Effects 0.000 abstract description 4
- 230000008845 photoaging Effects 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract description 2
- 239000002131 composite material Substances 0.000 abstract 1
- 239000006071 cream Substances 0.000 abstract 1
- 230000003020 moisturizing effect Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 43
- 239000000047 product Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000037307 sensitive skin Effects 0.000 description 2
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229940014041 hyaluronate Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/008—Preparations for oily skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种渗透肌肤的小分子组合物及其制备工艺，它涉及日用化工技术领域。其按质量百分比包括以下成分：A相物料：水79.01%、异戊二醇4%、丁二醇3%、霍霍巴蜡 PEG‑120 酯类0.11%；B相物料：烟酰胺0.8%、透明质酸钠0.5%、透明质酸钠交联聚合物0.11%、水解透明质酸钠0.11%、水解透明质酸0.11%、乙酰化透明质酸钠0.11%；C相物料：牡丹根皮提取物10%、β‑葡聚糖1.1%、1，2‑己二醇0.6%、寡肽‑1 0.11%、1，2‑戊二醇0.11%、四氢甲基嘧啶羧酸0.11%、肌肽0.11%。本发明制备简单，含五种小分子透明质酸，能被皮肤快速吸收，滋润补水，预防光老化，防止衰老，减少皱纹，具有良好的修复和护理皮肤作用。
Description
技术领域
本发明涉及的是日用化工技术领域，具体涉及一种渗透肌肤的小分子组合物及其制备工艺。
背景技术
随着生活品质的提高，人们越来越注重身体的美观、重视皮肤的护理，因此护肤品越来越受欢迎。其中精华液作为一种用于脸部护肤品中的精华素，能防衰老、抗皱、保湿、美白、去斑等，但目前市面上的精华液营养成分多为大分子结构，涂附在皮肤上需要较长时间被吸收，影响吸收效果。基于此，开发一种渗透肌肤的小分子组合物及其制备工艺尤为必要。
发明内容
针对现有技术上存在的不足，本发明目的是在于提供一种渗透肌肤的小分子组合物及其制备工艺，制备简单，制备而成的组合物含五种小分子透明质酸，能被皮肤快速吸收，滋润补水，调节肌肤水油平衡，预防光老化，防止衰老，减少皱纹，具有良好的修复和护理皮肤作用。
为了实现上述目的，本发明是通过如下的技术方案来实现：一种渗透肌肤的小分子组合物，按质量百分比包括以下成分：
A相物料：水79.01%、异戊二醇4%、丁二醇3%、霍霍巴蜡 PEG-120 酯类0.11%；
B相物料：烟酰胺0.8%、透明质酸钠0.5%、透明质酸钠交联聚合物0.11%、水解透明质酸钠0.11%、水解透明质酸0.11%、乙酰化透明质酸钠0.11%；
C相物料：牡丹根皮提取物10%、β-葡聚糖1.1%、1，2-己二醇0.6%、寡肽-1 0.11%、1，2-戊二醇0.11%、四氢甲基嘧啶羧酸0.11%、肌肽0.11%。
一种渗透肌肤的小分子组合物的制备工艺，其制备步骤为：
(1)准备原料：其中A相物料为水、异戊二醇、丁二醇、霍霍巴蜡 PEG-120 酯类，B相物料为烟酰胺、透明质酸钠、透明质酸钠交联聚合物、水解透明质酸钠、水解透明质酸、乙酰化透明质酸钠，C相物料为牡丹根皮提取物、β-葡聚糖、1，2-己二醇、寡肽-1、1，2-戊二醇、四氢甲基嘧啶羧酸、肌肽；
(2)预先将所用到的设备、工具消毒后用纯水冲洗干净；
(3)把A相物料依次加入到乳化锅内，在搅拌下加热至85℃，搅拌转速20r/min，搅拌至物料完全溶解，然后恒温搅拌30min灭菌；
(4)把B相物料依次加入，搅拌转速20r/min，搅拌时间30min，然后均质3min，转速为25r/min；
(5)冷却降温，在搅拌情况下将温度降至45℃；
(6)加入C相物料，搅拌至物料完全溶解，搅拌转速20r/min，搅拌时间30min；
(7)温度降至35℃，取样检验，合格后出料，送至静置间静置；
(8)静置后，检验员检测，检测合格后，灌装；
(9)准备好相对应的内外包材，进行灌装及包装，制成成品，标识清晰，经检验合格后入库。
作为优选，所述的步骤(6)生产配料时需补加2-3%的损耗水。
本发明的有益效果：本工艺制备简便，制成的组合物主要成分为小分子结构，使用时能被皮肤快速吸收，调节肌肤水油平衡，使肌肤透明亮丽，紧致肌肤，改善皮肤营养代谢，活化肌肤使皮肤恢复弹性保持年轻，对受损皮肤、敏感皮肤、创伤皮肤具有良好的修复和护理作用，有效预防光老化，应用前景广阔。
附图说明
下面结合附图和具体实施方式来详细说明本发明；
图1为本发明的工艺流程图。
具体实施方式
为使本发明实现的技术手段、创作特征、达成目的与功效易于明白了解，下面结合具体实施方式，进一步阐述本发明。
参照图1，本具体实施方式采用以下技术方案：一种渗透肌肤的小分子组合物，按质量百分比包括以下成分：
A相物料：水79.01%、异戊二醇4%、丁二醇3%、霍霍巴蜡 PEG-120 酯类0.11%；
B相物料：烟酰胺0.8%、透明质酸钠0.5%、透明质酸钠交联聚合物0.11%、水解透明质酸钠0.11%、水解透明质酸0.11%、乙酰化透明质酸钠0.11%；
C相物料：牡丹根皮提取物10%、β-葡聚糖1.1%、1，2-己二醇0.6%、寡肽-1 0.11%、1，2-戊二醇0.11%、四氢甲基嘧啶羧酸0.11%、肌肽0.11%。
一种渗透肌肤的小分子组合物的制备工艺，其制备步骤为：
(1)准备原料：其中A相物料为水、异戊二醇、丁二醇、霍霍巴蜡 PEG-120 酯类，B相物料为烟酰胺、透明质酸钠、透明质酸钠交联聚合物、水解透明质酸钠、水解透明质酸、乙酰化透明质酸钠，C相物料为牡丹根皮提取物、β-葡聚糖、1，2-己二醇、寡肽-1、1，2-戊二醇、四氢甲基嘧啶羧酸、肌肽；
(2)预先将所用到的设备、工具消毒后用纯水冲洗干净；
(3)把A相物料依次加入到乳化锅内，在搅拌下加热至85℃，搅拌转速20r/min，搅拌至物料完全溶解，然后恒温搅拌30min灭菌；
(4)把B相物料依次加入，搅拌转速20r/min，搅拌时间30min，然后均质3min，转速为25r/min；
(5)冷却降温，在搅拌情况下将温度降至45℃；
(6)加入C相物料，搅拌至物料完全溶解，搅拌转速20r/min，搅拌时间30min；生产配料时需补加2-3%的损耗水；
(7)温度降至35℃，取样检验，合格后出料，送至静置间静置；
(8)静置后，检验员检测，检测合格后，灌装；
(9)准备好相对应的内外包材，进行灌装及包装，制成成品，标识清晰，经检验合格后入库。
本具体实施方式制成的组合物含有透明质酸钠、透明质酸钠交联聚合物、水解透明质酸钠、水解透明质酸、乙酰化透明质酸钠这五种小分子透明质酸，能起到独特的保护皮肤作用，可保持皮肤滋润光滑、细腻柔嫩、富有弹性，具有防皱、抗皱、美容保健和恢复皮肤生理功能的作用。
本具体实施方式能够滋润补水，调节肌肤水油平衡，以达到通过保留皮肤水分、阻止水分经表皮流失，以及当皮肤受到损伤时的屏障修复目的，令皮肤使用后不会感到干燥，增加光泽，改善皮肤营养代谢，使皮肤柔和、光滑、去皱、增加弹性、防止衰老，减少皱纹，同时对受损皮肤、敏感皮肤、创伤皮肤具有良好的修复和护理作用；有效减少皮肤色素的沉着，修复受损细胞，减少紫外线对皮肤的伤害，减少晒后皮肤的黑斑生长，预防光老化，保持皮肤健康，注入活力，且制备简单，具有广阔的市场应用前景。
以上显示和描述了本发明的基本原理和主要特征和本发明的优点。本行业的技术人员应该了解，本发明不受上述实施例的限制，上述实施例和说明书中描述的只是说明本发明的原理，在不脱离本发明精神和范围的前提下，本发明还会有各种变化和改进，这些变化和改进都落入要求保护的本发明范围内。本发明要求保护范围由所附的权利要求书及其等效物界定。
Claims (3)
1.一种渗透肌肤的小分子组合物，其特征在于，按质量百分比包括以下成分：
A相物料：水79.01%、异戊二醇4%、丁二醇3%、霍霍巴蜡 PEG-120 酯类0.11%；
B相物料：烟酰胺0.8%、透明质酸钠0.5%、透明质酸钠交联聚合物0.11%、水解透明质酸钠0.11%、水解透明质酸0.11%、乙酰化透明质酸钠0.11%；
C相物料：牡丹根皮提取物10%、β-葡聚糖1.1%、1，2-己二醇0.6%、寡肽-1 0.11%、1，2-戊二醇0.11%、四氢甲基嘧啶羧酸0.11%、肌肽0.11%。
2.一种渗透肌肤的小分子组合物的制备工艺，其特征在于，其制备步骤为：
(1)准备原料：其中A相物料为水、异戊二醇、丁二醇、霍霍巴蜡 PEG-120 酯类，B相物料为烟酰胺、透明质酸钠、透明质酸钠交联聚合物、水解透明质酸钠、水解透明质酸、乙酰化透明质酸钠，C相物料为牡丹根皮提取物、β-葡聚糖、1，2-己二醇、寡肽-1、1，2-戊二醇、四氢甲基嘧啶羧酸、肌肽；
(2)预先将所用到的设备、工具消毒后用纯水冲洗干净；
(3)把A相物料依次加入到乳化锅内，在搅拌下加热至85℃，搅拌转速20r/min，搅拌至物料完全溶解，然后恒温搅拌30min灭菌；
(4)把B相物料依次加入，搅拌转速20r/min，搅拌时间30min，然后均质3min，转速为25r/min；
(5)冷却降温，在搅拌情况下将温度降至45℃；
(6)加入C相物料，搅拌至物料完全溶解，搅拌转速20r/min，搅拌时间30min；
(7)温度降至35℃，取样检验，合格后出料，送至静置间静置；
(8)静置后，检验员检测，检测合格后，灌装；
(9)准备好相对应的内外包材，进行灌装及包装，制成成品，标识清晰，经检验合格后入库。
3.根据权利要求2所述的一种渗透肌肤的小分子组合物的制备工艺，其特征在于，所述的步骤(6)生产配料时补加2-3%的损耗水。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111488212.5A CN114209622A (zh) | 2021-12-08 | 2021-12-08 | 一种渗透肌肤的小分子组合物及其制备工艺 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111488212.5A CN114209622A (zh) | 2021-12-08 | 2021-12-08 | 一种渗透肌肤的小分子组合物及其制备工艺 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114209622A true CN114209622A (zh) | 2022-03-22 |
Family
ID=80700175
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111488212.5A Pending CN114209622A (zh) | 2021-12-08 | 2021-12-08 | 一种渗透肌肤的小分子组合物及其制备工艺 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114209622A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117159424A (zh) * | 2023-09-25 | 2023-12-05 | 揭阳市嘉胜日用精细化工有限公司 | 一种保湿美白组合物及其应用 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109966231A (zh) * | 2019-04-11 | 2019-07-05 | 冯江 | 一种亮颜美肤霜及其制备方法 |
| KR102049698B1 (ko) * | 2019-06-28 | 2020-01-22 | 주식회사 신세계인터코스코리아 | 피부 개선용 화장료 조성물 |
| CN112870149A (zh) * | 2021-01-26 | 2021-06-01 | 广州华厦生物制药有限公司 | 植物蛋白修复原液及其制备工艺 |
-
2021
- 2021-12-08 CN CN202111488212.5A patent/CN114209622A/zh active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109966231A (zh) * | 2019-04-11 | 2019-07-05 | 冯江 | 一种亮颜美肤霜及其制备方法 |
| KR102049698B1 (ko) * | 2019-06-28 | 2020-01-22 | 주식회사 신세계인터코스코리아 | 피부 개선용 화장료 조성물 |
| CN112870149A (zh) * | 2021-01-26 | 2021-06-01 | 广州华厦生物制药有限公司 | 植物蛋白修复原液及其制备工艺 |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117159424A (zh) * | 2023-09-25 | 2023-12-05 | 揭阳市嘉胜日用精细化工有限公司 | 一种保湿美白组合物及其应用 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105232438A (zh) | 一种滋润修护面膜及其制备方法 | |
| CN105560119B (zh) | 一种牡丹保湿液及其制备方法 | |
| CN103816105B (zh) | 一种全效多功能护手霜及其制备方法 | |
| CN110314130B (zh) | 一种美白修复原液及其制备方法 | |
| CN103083214A (zh) | 一种芦荟保湿液及应用 | |
| CN112402347A (zh) | 一种含纤连蛋白的祛痘修复组合物及其制备方法 | |
| CN112773726A (zh) | 乙基双亚氨基甲基愈创木酚锰氯化物冻干粉及其制备方法 | |
| CN111514072B (zh) | 一种牛大力-诺丽复合酵素及其制备方法与在制备面膜中的应用 | |
| CN112773760A (zh) | 具有多重功效的组合物及多效精华液 | |
| CN114209622A (zh) | 一种渗透肌肤的小分子组合物及其制备工艺 | |
| CN111700814A (zh) | 一种含大麻叶提取物的舒缓修复面膜及其制备方法 | |
| CN111920742A (zh) | 一种壳聚糖多效修复面膜及制备方法 | |
| CN110368337B (zh) | 一种含玫瑰果提取物的面膜及制备方法 | |
| CN101721342B (zh) | 一种干膜状深海鱼皮胶原肽面膜及制备方法 | |
| CN112999105A (zh) | 一种高保湿的精华水及其制备方法 | |
| CN113081883A (zh) | 一种phar h皮肤玑理依克多因修护精华水及其生产工艺 | |
| CN111467299A (zh) | 一种多重修护密集补水玻尿酸原液及其制备方法 | |
| CN111374900A (zh) | 一种玫瑰花色素苷护肤鲜花水及其制备方法 | |
| CN110585079A (zh) | 一种含食源肽的抗辐射组合物及其抗辐射乳液 | |
| CN111012699A (zh) | 一种含褐藻糖海带提取物的抗氧化控油乳液 | |
| CN109276521A (zh) | 一种补水睡眠面膜及其制备方法 | |
| CN112545970B (zh) | 一种美容护肤珍珠膏及其制备方法 | |
| CN110840793B (zh) | 一种蚕丝蛋白面膜液及其制备方法 | |
| CN107281093B (zh) | 由动物胰脏制备保湿霜的方法及保湿霜 | |
| CN107308071A (zh) | 一种加入了聚谷氨酸的枸杞面膜及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220322 |